Back to results
Not yet recruitingPhase 1Phase 2

FMT in Triple Negative Breast Cancer Guided by ctDNA

NCT07292142

What is this trial?

Generating plain-language summary...

Am I eligible?

Generating eligibility summary...

What's involved?

Summarizing study design...

Where and how to apply

Primary location

London Health Sciences Center

London, Ontario, Canada

+2 additional locations

View on ClinicalTrials.gov
FMT in Triple Negative Breast Cancer Guided by ctDNA — TrialFind